Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab

The recent introduction of direct oral anticoagulants, including rivaroxaban, dabigatran, apixaban, and edoxaban, for the acute treatment and secondary prevention of venous thromboembolism and in atrial fibrillation has been shown to provide greater clinical benefit than oral vitamin K antagonists....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:SAGE Open Med Case Rep
Hoofdauteurs: Riario Sforza, Gian Galeazzo, Gentile, Francesco, Stock, Fabio, Caggiano, Francesco, Chiocca, Enrica, Incorvaia, Cristoforo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SAGE Publications 2018
Onderwerpen:
Case Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5768245/
https://ncbi.nlm.nih.gov/pubmed/29348918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X17753336
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items